Samsung Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Samsung Pharmaceutical Co Ltd with three other
companies in this sector in South Korea:
CMG Pharmaceutical Co Ltd
sales of 41.54 billion Korean Won [US$39.00 million]
of which 100%
was Pharmaceutial Manufacture),
Ildong Holdings Co Ltd
(41.07 billion Korean Won [US$38.57 million]
of which 32%
was Holdings), and
Kyung Nam Pharm Company Limited
(40.17 billion Korean Won [US$37.72 million]
During the year ended December of 2017, sales at
Samsung Pharmaceutical Co Ltd were 41.92 billion Korean Won (US$39.36 million).
decrease of 13.1%
versus 2016, when the company's sales were 48.22 billion Korean Won.
Contributing to the drop in overall sales was the 57.3% decline
in Health Food Segment, from 7.10 billion Korean Won to 3.03 billion Korean Won.
There were also decreases in sales in
Pharmaceuticals Segment (down 3.6% to 39.06 billion Korean Won)